Quality of life and treatment satisfaction in actual clinical practice of patients with Type 1 diabetes mellitus (T1DM) and hypoglycemia treated with insulin degludec.

CONCLUSIONS: The change to insulin degludec in patients with T1DM improved their metabolic control, increased their satisfaction with the insulin therapy and offered them improved quality of life. PMID: 29300101 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29300101?dopt=Abstract

Source: Current Medical Research and Opinion - January 5, 2018 Category: Research Tags: Curr Med Res Opin Source Type: research